Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ) Posted byZacks Equity Research February 25, 2022 Leave a comment on Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ) Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.